ArticleNPJ breast cancer2025

CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen.

Nealia C House et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.